Arrowhead Electronic Healthcare

Arrowhead was advised by Crosstree Capital Partners, Inc., and represents Crosstree's fourth transaction with UBC and its thirteenth pharmaceutical technology and technology-enabled solutions transaction.

Please direct inquiries to:


Shane C. Senior, CFA

Managing Director

Crosstree Capital Partners, Inc.

(813) 774-4755

All securities activities for this transaction were conducted by our affiliate, Crosstree Capital Securities LLC, a registered SEC broker-dealer and member of FINRA and SIPC.